Abstract
Background: Cervical lesions, induced by high-risk oncogenic human papillomavirus (HR-HPV), in the context of HIV remains a global health challenge. We determined the effect of HR-HPV on the development of cervical lesions in women with and without HIV infection. Methods: A cross-sectional analytical study was conducted among 257 women living in Cameroon. HIV serology, HR-HPV genotyping and cervico-vaginal smear (CVS) were performed for all participants; among those declared HIV positive, plasma HIV viral load and CD4 count were measured. Statistical analyses were performed using Graph Pad version 6.0; p<0.05 was considered statistically significant. Results: The mean age of the participants in our study was 37±6.5 years. According to HIV serology, 184 (71.59%) were HIV-positive versus 73 (28.40%) HIV-negative. Among the HIV-positive women, the median CD4 count was 438 [IQR: 317-597] cells/mm3 and the median viremia was <40 [IQR: <40 -2318] copies/mL. After successful genotyping, the prevalence of HR-HPV was 36.32% (73/201), with a significantly higher proportion in HIV-infected individuals (41.98% (55/131) versus 25.71% (18/70); p=0.02; OR=2.1). The overall rate of cervical lesions was 23.34% (60/257), with a non-significantly higher proportion in HIV-infected participants (25.00% (46/184) versus 19.17% (14/73); p=0.31). Relevantly, the presence of HR-HPV was significantly associated with cervical lesions (p<0.0001; OR=5.07), with a higher odds of cervical lesion in HIV-positive individuals (p<0.0001 and OR=5.67) compared to HIV-negative individuals (p=0.03 and OR=3.83). Conclusion: Although oncogenic HPV appears to be an independent factor in the development of cervical lesions, this study reveals higher odds of cervical lesions among HIV/HPV co-infection than in HPV infection alone.
Subject
Public Health, Environmental and Occupational Health
Reference45 articles.
1. Abbas JJ, Smith B, Poluta M, Velazquez-Berumen A. Improving health-care delivery in low-resource settings with nanotechnology. Nanobiomedicine [Internet]. 29 mars 2017 [cité 11 août 2020];4. Disponible sur: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5998261/
2. Gouda HN, Charlson F, Sorsdahl K, Ahmadzada S, Ferrari AJ, Erskine H, et al. Burden of non-communicable diseases in sub-Saharan Africa, 1990–2017: results from the Global Burden of Disease Study 2017. Lancet Glob Health [Internet]. 1 oct 2019 [cité 11 août 2020];7(10):e1375‑87. Disponible sur: https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(19)30374-2/abstract
3. Clifford G, Bertisch B, Franceschi S. Clifford et al. Respond to « Biological and Clinical Insights From Epidemiologic Research Into HIV, HPV, and Anal Cancer ». Am J Epidemiol. 15 sept 2013;178 (6):888‑9.
4. Catarino R, Vassilakos P, Tebeu P-M, Schäfer S, Bongoe A, Petignat P. Risk factors associated with human papillomavirus prevalence and cervical neoplasia among Cameroonian women. Cancer Epidemiol. févr 2016;40:60‑6.
5. Kjaer SK, Chackerian B, van den Brule AJ, Svare EI, Paull G, Walbomers JM, et al. High-risk human papillomavirus is sexually transmitted: evidence from a follow-up study of virgins starting sexual activity (intercourse). Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol. févr 2001;10(2):101‑6.